Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled phase 2 study of E2086 in adults with narcolepsy
CTR20261030Phase 2Active
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of E2086 in narcolepsy, sponsored by Eisai Co., Ltd.. Started May 2026; status: active.
02
Drugs
E2086
03
Conditions
narcolepsy
Beyond the preview
Go deeper on CTR20261030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261030.